Reply by Authors

Urol Pract. 2022 Sep;9(5):413. doi: 10.1097/UPJ.0000000000000316.03. Epub 2022 Aug 22.

Lior Taich¹, Hanson Zhao¹, Shannon R Stock^{2

3}, Lauren E Howard^{2

4}, Amanda M De Hoedt², Martha K Terris^{5

6}, Christopher L Amling⁷, Christopher J Kane⁸, Matthew R Cooperberg⁹, William J Aronson^{10

11}, Zachary Klaassen^{2

6}, Thomas J Polascik^{2

4

12}, Adriana C Vidal¹, Stephen J Freedland^{1

2}

¹ Department of Surgery, Division of Urology, Cedars-Sinai Medical Center, Los Angeles, California.
² Division of Urology, Durham Veterans Affairs Health Care System, Durham, North Carolina.
³ Department of Mathematics and Computer Science, College of the Holy Cross, Worcester, Massachusetts.
⁴ Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina.
⁵ Section of Urology, Veterans Affairs Medical Center, Augusta, Georgia.
⁶ Section of Urology, Augusta University-Medical College of Georgia, Augusta, Georgia.
⁷ Department of Urology, Oregon Health and Science University, Portland, Oregon.
⁸ Department of Urology, University of California San Diego Health System, San Diego, California.
⁹ Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
¹⁰ Department of Urology, UCLA School of Medicine, Los Angeles, California.
¹¹ Urology Section, Department of Surgery, Veterans Affairs Greater Los Angeles, Los Angeles, California.
¹² Division of Urology, Duke University School of Medicine, Durham, North Carolina.

No abstract available